
Die US-Demokraten haben Mails veröffentlicht, die aus dem Nachlass Epsteins stammen sollen. Darin ist auch von Donald Trump die Rede. Wie nah waren sich der Sexualstraftäter und der US-Präsident? Einst wollte Trump die Affäre aufklären, nun bremst er.
Deutschlandfunk

Die Währungs- und Wirtschaftsdominanz der USA sei keineswegs in Stein gemeisselt, sagt US-Ökonom Barry Eichengreen.
SRF Wirtschaft

Harvard physicists unveil system to solve long-standing barrier to new generation of supercomputers
Harvard University

Başak Çalı, Head of Research and Professor of International Law at the Bonavero Institute of Human Rights, Faculty of Law, asks whether judicial climate rulings can make a real difference to the climate crisis.
University of Oxford
Haaretz-Konferenz in Berlin: Was kommt nach dem Gaza-Krieg auf Israel und Deutschland zu? 14 Minuten
Heinrich Böll Stiftung

Russia and the US put nuclear testing back on the table. Is time running out for arms control? Expert comment LToremark 11 November 2025 Escalating tensions between the world’s two largest nuclear powers come only months before the last remaining US–Russia nuclear arms control treaty expires. Last week, Russia claimed to have successfully tested two nuclear-powered and nuclear-capable weapons: the Burevestnik cruise missile and the Poseidon underwater drone. The announcement comes only months before the last remaining nuclear arms control treaty between Russia and the US is due to expire. The New Strategic Arms Reduction Treaty (New START) places binding limits on the number of deployed strategic nuclear warheads and delivery systems by the world’s two largest nuclear powers. It is due to expire in February 2026, risking the removal of the final guardrail restraining the size and visibility of their arsenals – and increasing the risk of a new nuclear arms race. In a time of deep geopolitical mistrust and diminished diplomatic capacity, preventing escalation and preserving even minimal restraint is an urgent priority.Threats of nuclear testing Related work How likely is the use of nuclear weapons by Russia? Moscow’s announcement has been widely interpreted in the West as evidence of rapid Russian nuclear modernization and has caused alarm among policymakers and media outlets. Moscow has further stated that these new weapons are difficult to detect and capable of evading missile defences.However, there is no independent verification of these tests or the operational readiness of either system. Both have been under development for years and have faced repeated setbacks. The systems are based on old Soviet designs that could never be made operational due to technical challenges, raising significant questions about the authenticity of Moscow’s statements. The claims should therefore be understood, at least in part, as strategic signalling amid heightened nuclear posturing.The US response has further escalated tensions. After Russia’s announcement, President Trump instructed the State Department to restart US nuclear testing ‘on an equal basis’ to other countries. This statement has created confusion: no nuclear-armed state other than North Korea has conducted a nuclear explosive test since the 1990s. The US Department of Energy has since clarified that the US will conduct ‘non-critical explosions’ that are not nuclear detonations, and legislation has been introduced to prevent any president from authorizing such tests unilaterally. However, this ambiguity has already had consequences. Putin has ordered officials to draft proposals for resuming Russian nuclear testing, citing uncertainty over US intentions. The World Today Related work Why America may be triggering a new era of nuclear proliferation These developments threaten to collapse the three-decade long moratorium on nuclear tests. While a return to nuclear testing would not benefit the US – it already has the world’s largest archive of historical test data – other nuclear weapons states, particularly Russia and China, would stand to benefit more. But the danger is not simply that nuclear testing might resume. It is the escalation of nuclear threats and messaging at a time when trust is at its lowest point in decades, eroding the fragile foundation that post-Cold War arms control has been built upon. This highlights how nuclear rhetoric is increasingly deployed as a tool of political coercion – and how quickly restraint can unravel.The uncertain future of New STARTIn this climate, the impending expiration of New START is of particular concern as it cannot legally be extended again under its existing terms. Although Russia suspended its participation in the treaty in 2023, both Moscow and Washington have continued to observe the central numerical limits on deployed strategic warheads and delivery systems. Related work As nuclear negotiations show, US bilateral deal-making is no substitute for multilateralism Russia has proposed a voluntary one-year extension whereby both countries mutually commit to continuing to observe these limits. Trump has signalled openness to this idea, but no substantive progress has been made. Importantly, Russia’s claimed new delivery systems (if operational) would already fall under existing New START warhead and launcher limits.During his first term, Trump pushed for trilateral nuclear arms control negotiations with China, rather than advancing bilateral agreements. But involving China in negotiations around a New START extension should be avoided as it would risk stalling or sacrificing any progress altogether. Although China now has the world’s third largest nuclear arsenal, it remains significantly smaller than those of the US and Russia. China therefore has little incentive to accept constraints on its nuclear programme, meaning fruitful negotiations would be unlikely in the short term. If New START expires without even a symbolic extension, the consequences could be significant. The absence of mutually agreed constraints could fuel an arms race in which Russia and the US expand deployed nuclear arsenals, undermining strategic stability. If New START expires without even a symbolic extension, the consequences could be significant. This would weaken the credibility of the Nuclear Non-Proliferation Treaty (NPT), the main international treaty governing nuclear weapons. Many states already view nuclear weapons states as backsliding on their disarmament obligations. Abandoning the last bilateral nuclear arms control framework would reinforce that perception. While a one-year voluntary extension is not a long-term solution, it is likely the best available option in the current environment. Negotiating a new or more comprehensive treaty is unrealistic given geopolitical tensions, domestic political uncertainty in the US, and a weakened diplomatic and technical capacity within the US government, where key arms control posts remain unfilled.A strategy for stabilizationWhat is needed now is not an ambitious new treaty framework, but a focused effort to preserve the minimum conditions needed for future progress. The first step should be for the US and Russia to agree to a one-year voluntary extension of New START’s central limits. Although this would not restore trust between the countries or halt nuclear modernization programmes already underway, it would prevent immediate further deterioration of the global arms control architecture and lower the risk of miscalculations. It would also signal shared recognition that unconstrained nuclear competition benefits no one.
Chatham House

China’s tech advance means Western corporations must adapt to compete Expert comment thilton.drupal 11 November 2025 Western policymakers should wake up to China’s emerging tech dominance and seek to self-strengthen to withstand the disruptive power of Chinese tech giants. China is winning the tech race against the US in almost all sectors and leaving Europe far behind. Saying this would have been controversial only a few short months ago, but such a realization is now becoming more mainstream. Jim Farley, the CEO of US car giant Ford, warned last month: ‘They have enough [production] capacity in China with existing factories to serve the entire North American market, put us all out of business. Japan never had that, so this is a completely different level of risk for our industry.’And Jensen Huang, CEO of the world’s most valuable company, Nvidia, had a similar take: ‘China is going to win the AI race.’ China is winning the tech race against the US in almost all sectors and leaving Europe far behind. The risk to some of the largest corporations in the West is stark. As Chinese companies ascend to the cutting edge of global tech, often offering products at sharp discounts to those of Western competitors, disruptive shocks have started to hit some of the West’s largest and most famous corporations. Disruption events come in different forms. Some are preceded by CEO warnings over Chinese competition. These may be followed by the ceding of market share to Chinese competitors either in China itself or in markets overseas. Later, evidence of disruption may come with lowered earnings’ forecasts and the issuance of guidance to shareholders.There is no doubt that Chinese companies are making rapid strides in technological upgrading, often through innovation. Research from the Australian Strategic Policy Institute (ASPI) shows that China leads the US in 57 out of 64 critical technology categories. In the period between 2003-2007, ASPI found that China led in just three of the 64 technologies assessed.Examples from three key industries – pharmaceuticals, electric vehicles and wind power – among many others highlight the impact of China’s disruptive shocks. If Western corporations are to weather these shocks, they need to self-strengthen and adapt with various strategies, supported by meaningful government-led industrial policy. PharmaceuticalsThe challenges faced by Merck and Co, a large US pharmaceutical company, reveal the disruptive power of emerging Chinese pharma companies. Merck’s share price plunged on a few occasions in 2024 and early 2025 due to the declining sales of a popular HPV vaccine, Gardasil, in China. The stress the company felt was partly due to the emergence of a Chinese competitor drug, Cecolin 9, developed by Xiamen Innovax Biotech. The price of Cecolin 9 was set at a 60 per cent discount to that of Merck’s Gardasil.On February 4 this year, Merck shares tumbled 11 per cent in early trade after the company announced it would temporarily halt shipments of Gardasil to China. While Merck said it remained confident in Gardasil’s future sales prospects in China overall, it withdrew its long-term $11bn sales target for the vaccine. Related work China’s economic model will continue to alarm its trading partners Another potential disruption to Merck’s business comes from Akeso, a Chinese biotech company that beat Merck’s Keytruda, a multibillion dollar blockbuster cancer drug, in a head-to-head trial. Akeso won approvals in China for its new drug, ivonescimab, which is now on sale in the country.China’s position as a global leader in pharmaceutical R&D is demonstrated by a series of announcements by European companies to boost their research presence in China. UK-based AstraZeneca pledged this year to build a $2.5bn R&D hub in Beijing. Novo Nordisk, the Denmark-based company, and Roche Group, the Swiss giant, have also announced large expansion plans in China.Electric and hybrid vehiclesChina’s march into electric and hybrid vehicle markets around the world is the most commonly cited example of its disruptive technological power. In September this year, Chinese car companies captured a record 7.4 per cent of all passenger car sales across Europe, up from 3.9 per cent at the start of the year. Some Chinese car companies posted bumper increases in Europe sales. BYD registered a 304 per cent increase in year-on-year sales in the first nine months of this year, while Chery notched up an 862 per cent rise and Leapmotor, which makes ultra-affordable cars, posted a 7,108 per cent increase. The risk to some of the largest corporations in the West is stark. Carlos Tavares, former CEO of Stellantis, warned last month that as Western carmakers stumble, Chinese competitors will be ready to snap them up. ‘The day a Western carmaker is in severe difficulty, with factories on the verge of closing and demonstrations in the street, a Chinese carmaker will come and say ‘I’ll take it and keep the jobs’, and they’ll be considered saviours,’ Tavares said.The share prices of VW, Mercedes Benz, Stellantis and other European automakers are sharply down from the highs they hit in recent years.Wind powerChinese manufacturers of wind turbines have been gaining global market share. In 2024, Chinese companies took six out of the top 10 slots for turbine makers worldwide, according to Bloomberg. Among these, the top four places went to Chinese makers for the first time. European and US manufacturers fell out of the top three, also for the first time.China’s rise is propelled by a domestic market that installed about 80GW of wind power last year alone, or about 60 per cent of the extra capacity installed globally. But the competitive challenge that leading companies such as Goldwind, Envision and Mingyang present to Western competitors GE, Siemens Energy and Vestas lies mainly in the fact that Chinese-made turbines can be up to 50 per cent cheaper. Technological disruption is also underway. Dongfang Electric, a Chinese company, also took the mantle for making the world’s most powerful turbine – a 26MW offshore prototype with blades that are 153 meters in length – from Siemens Gamesa earlier this year. This technological breakthrough is likely to further reduce the cost per unit of electricity generated.How Western corporations can adaptChinese companies are dominating globally or taking greater market share in a range of other industries, including cellular modules, lithium-ion batteries, 5G telecoms equipment, solar power, nuclear power, factory automation, robotics (including humanoid robots), electrical equipment and more.Disruptive events are likely to grow more common across all these key sectors. Western corporations therefore need to adopt a series of strategies to self-strengthen and pre-empt disruptive events before they happen. These strategies may include climbing the technology ladder, including by investing heavily in R&D inside China as, for example, Germany’s VW and Mercedes Benz have done. Western corporations may also consider restructuring to cut costs, so they are better able to compete with Chinese price-setters, as well as strategic alliances to create efficiencies and boost brands.
Chatham House
